O'Donnell M — Endo Lab

2012

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Lancet (London, England) ·doi:10.1016/s0140-6736(12)61728-0

BackgroundReliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD…

2012

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Lancet (London, England) ·doi:10.1016/s0140-6736(12)61729-2

BackgroundNon-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the o…

article 1992

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid

Atherosclerosis ·doi:10.1016/0021-9150(92)90008-5

Serum levels of lipids, lipoproteins and apolipoproteins were measured in 26 premenopausal women with endometriosis both before and after six months therapy with the anabolic steroid danazol (600 mg/day) and in 15 untreated women who acted …